Cambridge Research Biochemicals (CRB) was aquired by Biosynth in May 2023 and changed its name to Biosynth Laboratories Limited in June 2023. Biosynth Laboratories is a leading independent producer of custom-made peptide and antibody tools, supplying researchers in the pharmaceutical, life science and academic sectors worldwide. The primary applications of its products are as custom-made, laboratory scale reagents for proof of principle studies within early phase drug discovery and to support immunoassay and biomarker programmes in clinical studies. The company produces all flavours of peptides from simple to modified, stable and radio-labelled to dye labelled from milligrams to gram-scale to the highest levels of purity. Biosynth has an enviable track record for generating target specific polyclonal antibodies with modifications and labelling and Infinity antibodies: custom generated monoclonal antibodies to challenging antigens.

 

Biosynth also has an extensive catalogue of research products comprising: Peptides & Antibodies, Comples Chemicals (Carbohydrates, Enzymes) and Biologics.